Kaplan-Meier survival analysis, ROC curves for 1, 3, and 5-year survival intervals, and multivariate Cox regression analysis all consistently indicated that KIF18B may function as an independent predictor of unfavorable prognosis in glioma patients. This evidence concerns the gene KIF18B and glioma.